Concepts (148)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplastic Cells, Circulating | 9 | 2016 | 607 | 0.640 |
Why?
|
| Troponin T | 2 | 2020 | 261 | 0.300 |
Why?
|
| Color | 2 | 2014 | 66 | 0.240 |
Why?
|
| Precision Medicine | 1 | 2010 | 1154 | 0.210 |
Why?
|
| Bence Jones Protein | 1 | 2001 | 10 | 0.200 |
Why?
|
| Biomarkers | 3 | 2020 | 5047 | 0.200 |
Why?
|
| Ovarian Neoplasms | 3 | 2024 | 4638 | 0.190 |
Why?
|
| Biomarkers, Tumor | 8 | 2024 | 10331 | 0.190 |
Why?
|
| Endometrial Neoplasms | 2 | 2024 | 1341 | 0.180 |
Why?
|
| Autoantibodies | 1 | 2024 | 576 | 0.180 |
Why?
|
| Immunoglobulin M | 3 | 2005 | 347 | 0.170 |
Why?
|
| Bone Neoplasms | 4 | 2014 | 2576 | 0.170 |
Why?
|
| Urinalysis | 2 | 2013 | 84 | 0.140 |
Why?
|
| Blood Specimen Collection | 1 | 2016 | 93 | 0.130 |
Why?
|
| CA-125 Antigen | 3 | 2024 | 226 | 0.130 |
Why?
|
| Waldenstrom Macroglobulinemia | 1 | 2019 | 273 | 0.130 |
Why?
|
| Paraproteins | 2 | 2005 | 39 | 0.130 |
Why?
|
| Breast Neoplasms | 7 | 2014 | 15694 | 0.130 |
Why?
|
| Acute Coronary Syndrome | 1 | 2018 | 259 | 0.130 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2016 | 203 | 0.120 |
Why?
|
| Trans-Activators | 1 | 2001 | 1555 | 0.120 |
Why?
|
| Tacrolimus | 1 | 2015 | 335 | 0.120 |
Why?
|
| Blood Chemical Analysis | 1 | 2014 | 118 | 0.120 |
Why?
|
| Ketones | 1 | 2013 | 54 | 0.110 |
Why?
|
| Procollagen | 1 | 2012 | 31 | 0.110 |
Why?
|
| Prostate-Specific Antigen | 3 | 2018 | 993 | 0.110 |
Why?
|
| Bilirubin | 1 | 2013 | 221 | 0.110 |
Why?
|
| Antigens, Neoplasm | 1 | 2018 | 1506 | 0.100 |
Why?
|
| Dietary Fiber | 1 | 2011 | 123 | 0.100 |
Why?
|
| Myocardial Infarction | 1 | 2020 | 1374 | 0.100 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2016 | 716 | 0.090 |
Why?
|
| Early Detection of Cancer | 1 | 2018 | 1258 | 0.090 |
Why?
|
| Prostatic Neoplasms | 3 | 2018 | 5767 | 0.080 |
Why?
|
| DNA-Binding Proteins | 1 | 2001 | 4821 | 0.080 |
Why?
|
| Sensitivity and Specificity | 3 | 2024 | 4971 | 0.080 |
Why?
|
| Peptide Fragments | 1 | 2012 | 1271 | 0.070 |
Why?
|
| Predictive Value of Tests | 4 | 2024 | 4892 | 0.070 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2010 | 1226 | 0.070 |
Why?
|
| Middle Aged | 16 | 2019 | 86204 | 0.070 |
Why?
|
| Humans | 26 | 2024 | 261506 | 0.070 |
Why?
|
| Thyroid Neoplasms | 1 | 2016 | 1866 | 0.070 |
Why?
|
| Antibodies, Catalytic | 1 | 2004 | 9 | 0.060 |
Why?
|
| Paraproteinemias | 1 | 2005 | 61 | 0.060 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 2004 | 62 | 0.060 |
Why?
|
| Female | 17 | 2024 | 141928 | 0.060 |
Why?
|
| Positron-Emission Tomography | 2 | 2010 | 2173 | 0.060 |
Why?
|
| Immunoelectrophoresis | 1 | 2001 | 40 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2014 | 6207 | 0.050 |
Why?
|
| ROC Curve | 1 | 2024 | 1183 | 0.050 |
Why?
|
| Male | 11 | 2020 | 123000 | 0.050 |
Why?
|
| Prognosis | 6 | 2016 | 21713 | 0.040 |
Why?
|
| Adult | 10 | 2018 | 77950 | 0.040 |
Why?
|
| Aged | 10 | 2018 | 70117 | 0.040 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2020 | 173 | 0.040 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2019 | 155 | 0.040 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2001 | 622 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2024 | 1863 | 0.040 |
Why?
|
| Aged, 80 and over | 6 | 2014 | 29902 | 0.040 |
Why?
|
| Biological Assay | 1 | 2018 | 177 | 0.040 |
Why?
|
| Blood Urea Nitrogen | 1 | 2016 | 95 | 0.040 |
Why?
|
| Chemistry, Clinical | 1 | 2016 | 18 | 0.040 |
Why?
|
| Lymphoma | 1 | 2005 | 1467 | 0.030 |
Why?
|
| Leukemia | 1 | 2005 | 1635 | 0.030 |
Why?
|
| Reference Values | 1 | 2018 | 1099 | 0.030 |
Why?
|
| Magnesium | 1 | 2016 | 160 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 7789 | 0.030 |
Why?
|
| Mass Screening | 1 | 2024 | 1509 | 0.030 |
Why?
|
| Retrospective Studies | 6 | 2018 | 37905 | 0.030 |
Why?
|
| Potassium | 1 | 2016 | 329 | 0.030 |
Why?
|
| Quality Control | 1 | 2016 | 457 | 0.030 |
Why?
|
| Methemoglobin | 1 | 2014 | 9 | 0.030 |
Why?
|
| Immunoassay | 1 | 2015 | 216 | 0.030 |
Why?
|
| Dysuria | 1 | 2013 | 7 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2015 | 342 | 0.030 |
Why?
|
| Urological Agents | 1 | 2013 | 6 | 0.030 |
Why?
|
| Creatinine | 1 | 2016 | 531 | 0.030 |
Why?
|
| Rosaniline Dyes | 1 | 2014 | 108 | 0.030 |
Why?
|
| Heart | 1 | 2020 | 1223 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 2010 | 4849 | 0.030 |
Why?
|
| Coloring Agents | 1 | 2014 | 234 | 0.030 |
Why?
|
| Proportional Hazards Models | 2 | 2014 | 4988 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2009 | 7551 | 0.030 |
Why?
|
| Neoplasm Metastasis | 2 | 2016 | 5112 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2015 | 368 | 0.030 |
Why?
|
| Osteocalcin | 1 | 2012 | 87 | 0.030 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2005 | 2390 | 0.030 |
Why?
|
| Erythrocytes | 1 | 2013 | 339 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2018 | 12873 | 0.030 |
Why?
|
| Collagen Type I | 1 | 2012 | 204 | 0.030 |
Why?
|
| alpha-Tocopherol | 1 | 2011 | 78 | 0.030 |
Why?
|
| Disease Progression | 2 | 2014 | 6682 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2001 | 4744 | 0.030 |
Why?
|
| Carotenoids | 1 | 2011 | 96 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2016 | 2292 | 0.020 |
Why?
|
| Disease-Free Survival | 2 | 2014 | 10001 | 0.020 |
Why?
|
| Survival | 1 | 2010 | 177 | 0.020 |
Why?
|
| Emergency Service, Hospital | 1 | 2018 | 1148 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2013 | 461 | 0.020 |
Why?
|
| Glucose | 1 | 2016 | 1248 | 0.020 |
Why?
|
| Fruit | 1 | 2011 | 294 | 0.020 |
Why?
|
| Calcium | 1 | 2016 | 1537 | 0.020 |
Why?
|
| Anti-Infective Agents | 1 | 2013 | 446 | 0.020 |
Why?
|
| Multiple Myeloma | 1 | 2001 | 2138 | 0.020 |
Why?
|
| Cell Count | 1 | 2010 | 508 | 0.020 |
Why?
|
| Vegetables | 1 | 2011 | 325 | 0.020 |
Why?
|
| Tomography, Emission-Computed | 1 | 2010 | 310 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2012 | 1546 | 0.020 |
Why?
|
| Kidney Transplantation | 1 | 2015 | 755 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2015 | 1375 | 0.020 |
Why?
|
| Counseling | 1 | 2011 | 381 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2016 | 14551 | 0.020 |
Why?
|
| Trastuzumab | 1 | 2011 | 696 | 0.020 |
Why?
|
| Cytological Techniques | 1 | 2008 | 74 | 0.020 |
Why?
|
| Bevacizumab | 1 | 2011 | 938 | 0.020 |
Why?
|
| Peptides | 1 | 2012 | 1479 | 0.020 |
Why?
|
| Quinazolines | 1 | 2011 | 923 | 0.020 |
Why?
|
| Survivors | 1 | 2011 | 1031 | 0.020 |
Why?
|
| Blood Protein Electrophoresis | 1 | 2005 | 9 | 0.020 |
Why?
|
| Survival Rate | 2 | 2009 | 12221 | 0.020 |
Why?
|
| ZAP-70 Protein-Tyrosine Kinase | 1 | 2005 | 102 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2014 | 4844 | 0.020 |
Why?
|
| Neoplasm Staging | 2 | 2011 | 13658 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 2010 | 1301 | 0.020 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2004 | 99 | 0.020 |
Why?
|
| Catalysis | 1 | 2004 | 250 | 0.010 |
Why?
|
| Prostatectomy | 1 | 2008 | 962 | 0.010 |
Why?
|
| ErbB Receptors | 1 | 2011 | 2295 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2011 | 5637 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2009 | 4298 | 0.010 |
Why?
|
| Kinetics | 1 | 2004 | 2049 | 0.010 |
Why?
|
| Receptor, ErbB-2 | 1 | 2010 | 2518 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 2005 | 1681 | 0.010 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2011 | 3251 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2004 | 2314 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2010 | 8865 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2005 | 3033 | 0.010 |
Why?
|
| Chromosome Aberrations | 1 | 2005 | 1960 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2005 | 1756 | 0.010 |
Why?
|
| Bone Marrow | 1 | 2005 | 2358 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2008 | 9244 | 0.010 |
Why?
|
| Models, Biological | 1 | 2004 | 3254 | 0.010 |
Why?
|
| Time Factors | 1 | 2008 | 12926 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 7548 | 0.010 |
Why?
|
| Young Adult | 1 | 2010 | 21445 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2004 | 4367 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2009 | 32848 | 0.000 |
Why?
|
| Mice | 1 | 2004 | 34495 | 0.000 |
Why?
|
| Animals | 1 | 2004 | 59536 | 0.000 |
Why?
|